nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ANXA1—stomach cancer	0.284	0.694	CbGaD
Dexamethasone—CYP2A6—stomach cancer	0.087	0.213	CbGaD
Dexamethasone—NOS2—Doxorubicin—stomach cancer	0.0644	0.182	CbGbCtD
Dexamethasone—PTGS2—stomach cancer	0.0381	0.0932	CbGaD
Dexamethasone—CYP1B1—Docetaxel—stomach cancer	0.0206	0.0583	CbGbCtD
Dexamethasone—ABCB1—Mitomycin—stomach cancer	0.0188	0.0531	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—stomach cancer	0.0154	0.0434	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—stomach cancer	0.0154	0.0434	CbGbCtD
Dexamethasone—ABCC2—Irinotecan—stomach cancer	0.0148	0.0418	CbGbCtD
Dexamethasone—CYP2A6—Fluorouracil—stomach cancer	0.0139	0.0392	CbGbCtD
Dexamethasone—ABCG2—Irinotecan—stomach cancer	0.0134	0.0378	CbGbCtD
Dexamethasone—ABCG2—Fluorouracil—stomach cancer	0.0128	0.0363	CbGbCtD
Dexamethasone—ABCC2—Docetaxel—stomach cancer	0.0108	0.0306	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.00987	0.0279	CbGbCtD
Dexamethasone—CYP3A7—Irinotecan—stomach cancer	0.00987	0.0279	CbGbCtD
Dexamethasone—ABCG2—Docetaxel—stomach cancer	0.00979	0.0277	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—stomach cancer	0.00943	0.0267	CbGbCtD
Dexamethasone—CYP2B6—Irinotecan—stomach cancer	0.0094	0.0266	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—stomach cancer	0.00807	0.0228	CbGbCtD
Dexamethasone—CYP2C9—Capecitabine—stomach cancer	0.00804	0.0227	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—stomach cancer	0.00782	0.0221	CbGbCtD
Dexamethasone—CYP3A5—Irinotecan—stomach cancer	0.0074	0.0209	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—stomach cancer	0.0073	0.0207	CbGbCtD
Dexamethasone—CYP3A7—Docetaxel—stomach cancer	0.00723	0.0205	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.00723	0.0205	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—stomach cancer	0.00707	0.02	CbGbCtD
Dexamethasone—CYP2C8—Fluorouracil—stomach cancer	0.00683	0.0193	CbGbCtD
Dexamethasone—CYP3A5—Docetaxel—stomach cancer	0.00543	0.0153	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—stomach cancer	0.00513	0.0145	CbGbCtD
Dexamethasone—ABCB1—Irinotecan—stomach cancer	0.00482	0.0136	CbGbCtD
Dexamethasone—CYP2C9—Fluorouracil—stomach cancer	0.00476	0.0135	CbGbCtD
Dexamethasone—ABCB11—bile—stomach cancer	0.00476	0.093	CbGeAlD
Dexamethasone—ABCB1—Docetaxel—stomach cancer	0.00353	0.00999	CbGbCtD
Dexamethasone—CYP3A4—Irinotecan—stomach cancer	0.00289	0.00817	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—stomach cancer	0.00263	0.00745	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—stomach cancer	0.00255	0.00721	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—stomach cancer	0.00248	0.00702	CbGbCtD
Dexamethasone—ABCC2—bile—stomach cancer	0.00242	0.0473	CbGeAlD
Dexamethasone—CYP3A4—Docetaxel—stomach cancer	0.00212	0.00599	CbGbCtD
Dexamethasone—PLA2G1B—blood vessel—stomach cancer	0.00181	0.0353	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—stomach cancer	0.00158	0.00446	CbGbCtD
Dexamethasone—ANXA1—gall bladder—stomach cancer	0.0013	0.0254	CbGeAlD
Dexamethasone—PLA2G1B—hematopoietic system—stomach cancer	0.000962	0.0188	CbGeAlD
Dexamethasone—CYP3A43—endocrine gland—stomach cancer	0.000936	0.0183	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—stomach cancer	0.000879	0.0172	CbGeAlD
Dexamethasone—CYP3A43—liver—stomach cancer	0.000844	0.0165	CbGeAlD
Dexamethasone—PGR—blood vessel—stomach cancer	0.000832	0.0162	CbGeAlD
Dexamethasone—CYP4A11—digestive system—stomach cancer	0.000807	0.0158	CbGeAlD
Dexamethasone—PLA2G1B—pancreas—stomach cancer	0.000783	0.0153	CbGeAlD
Dexamethasone—NR0B1—endocrine gland—stomach cancer	0.000776	0.0152	CbGeAlD
Dexamethasone—Amcinonide—ANXA1—stomach cancer	0.000743	0.548	CrCbGaD
Dexamethasone—ANXA1—hematopoietic system—stomach cancer	0.000736	0.0144	CbGeAlD
Dexamethasone—ANXA1—epithelium—stomach cancer	0.000673	0.0131	CbGeAlD
Dexamethasone—PLA2G1B—digestive system—stomach cancer	0.000669	0.0131	CbGeAlD
Dexamethasone—CYP4A11—endocrine gland—stomach cancer	0.000667	0.013	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—stomach cancer	0.000648	0.0127	CbGeAlD
Dexamethasone—CYP11A1—hematopoietic system—stomach cancer	0.000613	0.012	CbGeAlD
Dexamethasone—CYP4A11—liver—stomach cancer	0.000602	0.0117	CbGeAlD
Dexamethasone—ANXA1—pancreas—stomach cancer	0.000599	0.0117	CbGeAlD
Dexamethasone—PLA2G1B—endocrine gland—stomach cancer	0.000553	0.0108	CbGeAlD
Dexamethasone—ABCB11—digestive system—stomach cancer	0.00052	0.0102	CbGeAlD
Dexamethasone—ANXA1—lymphoid tissue—stomach cancer	0.000518	0.0101	CbGeAlD
Dexamethasone—ANXA1—digestive system—stomach cancer	0.000512	0.00999	CbGeAlD
Dexamethasone—NR3C2—hematopoietic system—stomach cancer	0.000476	0.0093	CbGeAlD
Dexamethasone—ANXA1—bone marrow—stomach cancer	0.000472	0.00921	CbGeAlD
Dexamethasone—PGR—hematopoietic system—stomach cancer	0.000443	0.00865	CbGeAlD
Dexamethasone—ABCB11—endocrine gland—stomach cancer	0.00043	0.0084	CbGeAlD
Dexamethasone—ANXA1—endocrine gland—stomach cancer	0.000423	0.00826	CbGeAlD
Dexamethasone—CYP3A7—endocrine gland—stomach cancer	0.00042	0.00821	CbGeAlD
Dexamethasone—NR3C2—smooth muscle tissue—stomach cancer	0.00042	0.00819	CbGeAlD
Dexamethasone—PTGS2—blood vessel—stomach cancer	0.000415	0.00811	CbGeAlD
Dexamethasone—SLCO1A2—hematopoietic system—stomach cancer	0.000408	0.00798	CbGeAlD
Dexamethasone—PGR—epithelium—stomach cancer	0.000405	0.00791	CbGeAlD
Dexamethasone—CYP19A1—hematopoietic system—stomach cancer	0.000399	0.00778	CbGeAlD
Dexamethasone—PTGS2—gall bladder—stomach cancer	0.000391	0.00763	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—stomach cancer	0.00039	0.00762	CbGeAlD
Dexamethasone—ABCB11—liver—stomach cancer	0.000388	0.00757	CbGeAlD
Dexamethasone—ANXA1—liver—stomach cancer	0.000381	0.00744	CbGeAlD
Dexamethasone—CYP3A7—liver—stomach cancer	0.000379	0.0074	CbGeAlD
Dexamethasone—CYP17A1—endocrine gland—stomach cancer	0.000379	0.0074	CbGeAlD
Dexamethasone—CYP1B1—hematopoietic system—stomach cancer	0.000373	0.00728	CbGeAlD
Dexamethasone—CYP11A1—endocrine gland—stomach cancer	0.000353	0.00688	CbGeAlD
Dexamethasone—CYP17A1—liver—stomach cancer	0.000342	0.00667	CbGeAlD
Dexamethasone—NR3C2—digestive system—stomach cancer	0.000331	0.00647	CbGeAlD
Dexamethasone—CYP1B1—smooth muscle tissue—stomach cancer	0.000328	0.00641	CbGeAlD
Dexamethasone—CYP2C19—hematopoietic system—stomach cancer	0.000327	0.00638	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—liver—stomach cancer	0.000322	0.00629	CbGeAlD
Dexamethasone—Hydrocortisone—ANXA1—stomach cancer	0.000313	0.231	CrCbGaD
Dexamethasone—PGR—lymphoid tissue—stomach cancer	0.000312	0.00609	CbGeAlD
Dexamethasone—ANXA1—lymph node—stomach cancer	0.000292	0.00571	CbGeAlD
Dexamethasone—CYP2C8—hematopoietic system—stomach cancer	0.000285	0.00557	CbGeAlD
Dexamethasone—SLCO1A2—digestive system—stomach cancer	0.000284	0.00555	CbGeAlD
Dexamethasone—NR3C2—endocrine gland—stomach cancer	0.000274	0.00535	CbGeAlD
Dexamethasone—ABCC2—digestive system—stomach cancer	0.000265	0.00517	CbGeAlD
Dexamethasone—CYP1A1—hematopoietic system—stomach cancer	0.000263	0.00514	CbGeAlD
Dexamethasone—CYP2A6—liver—stomach cancer	0.000263	0.00514	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—stomach cancer	0.000262	0.00512	CbGeAlD
Dexamethasone—CYP17A1—lymph node—stomach cancer	0.000262	0.00511	CbGeAlD
Dexamethasone—CYP1B1—digestive system—stomach cancer	0.000259	0.00506	CbGeAlD
Dexamethasone—CYP3A5—hematopoietic system—stomach cancer	0.000258	0.00503	CbGeAlD
Dexamethasone—ABCB1—blood vessel—stomach cancer	0.000257	0.00502	CbGeAlD
Dexamethasone—CYP2B6—hematopoietic system—stomach cancer	0.000256	0.005	CbGeAlD
Dexamethasone—NR3C1—hematopoietic system—stomach cancer	0.000256	0.00499	CbGeAlD
Dexamethasone—PGR—endocrine gland—stomach cancer	0.000255	0.00497	CbGeAlD
Dexamethasone—CYP2C9—hematopoietic system—stomach cancer	0.000253	0.00495	CbGeAlD
Dexamethasone—NR3C2—liver—stomach cancer	0.000247	0.00482	CbGeAlD
Dexamethasone—CYP11A1—lymph node—stomach cancer	0.000244	0.00476	CbGeAlD
Dexamethasone—CYP1A1—epithelium—stomach cancer	0.000241	0.0047	CbGeAlD
Dexamethasone—CYP2E1—hematopoietic system—stomach cancer	0.00024	0.00469	CbGeAlD
Dexamethasone—SLCO1A2—endocrine gland—stomach cancer	0.000235	0.00458	CbGeAlD
Dexamethasone—NR3C1—epithelium—stomach cancer	0.000234	0.00456	CbGeAlD
Dexamethasone—CYP19A1—endocrine gland—stomach cancer	0.000229	0.00447	CbGeAlD
Dexamethasone—CYP2C19—digestive system—stomach cancer	0.000227	0.00444	CbGeAlD
Dexamethasone—NR3C1—smooth muscle tissue—stomach cancer	0.000225	0.0044	CbGeAlD
Dexamethasone—PTGS2—hematopoietic system—stomach cancer	0.000221	0.00432	CbGeAlD
Dexamethasone—ABCC2—endocrine gland—stomach cancer	0.000219	0.00427	CbGeAlD
Dexamethasone—CYP1B1—endocrine gland—stomach cancer	0.000214	0.00418	CbGeAlD
Dexamethasone—SLCO1A2—liver—stomach cancer	0.000212	0.00413	CbGeAlD
Dexamethasone—CYP3A5—pancreas—stomach cancer	0.00021	0.0041	CbGeAlD
Dexamethasone—NR3C1—pancreas—stomach cancer	0.000208	0.00406	CbGeAlD
Dexamethasone—CYP19A1—liver—stomach cancer	0.000206	0.00403	CbGeAlD
Dexamethasone—PTGS2—epithelium—stomach cancer	0.000202	0.00395	CbGeAlD
Dexamethasone—ABCC2—liver—stomach cancer	0.000197	0.00385	CbGeAlD
Dexamethasone—PTGS2—smooth muscle tissue—stomach cancer	0.000195	0.0038	CbGeAlD
Dexamethasone—CYP3A4—hematopoietic system—stomach cancer	0.000193	0.00377	CbGeAlD
Dexamethasone—CYP1B1—liver—stomach cancer	0.000193	0.00377	CbGeAlD
Dexamethasone—CYP2D6—hematopoietic system—stomach cancer	0.00019	0.00371	CbGeAlD
Dexamethasone—NR3C2—lymph node—stomach cancer	0.000189	0.0037	CbGeAlD
Dexamethasone—CYP2C19—endocrine gland—stomach cancer	0.000188	0.00367	CbGeAlD
Dexamethasone—CYP1A1—digestive system—stomach cancer	0.000183	0.00358	CbGeAlD
Dexamethasone—CYP2B6—lymphoid tissue—stomach cancer	0.00018	0.00352	CbGeAlD
Dexamethasone—PTGS2—pancreas—stomach cancer	0.00018	0.00352	CbGeAlD
Dexamethasone—NR3C1—lymphoid tissue—stomach cancer	0.00018	0.00351	CbGeAlD
Dexamethasone—CYP3A5—digestive system—stomach cancer	0.000179	0.0035	CbGeAlD
Dexamethasone—CYP2B6—digestive system—stomach cancer	0.000178	0.00348	CbGeAlD
Dexamethasone—ABCG2—bone marrow—stomach cancer	0.000178	0.00347	CbGeAlD
Dexamethasone—NR3C1—digestive system—stomach cancer	0.000178	0.00347	CbGeAlD
Dexamethasone—CYP2C9—digestive system—stomach cancer	0.000176	0.00344	CbGeAlD
Dexamethasone—PGR—lymph node—stomach cancer	0.000176	0.00344	CbGeAlD
Dexamethasone—CYP2C19—liver—stomach cancer	0.000169	0.00331	CbGeAlD
Dexamethasone—CYP2E1—lymphoid tissue—stomach cancer	0.000169	0.0033	CbGeAlD
Dexamethasone—CYP2E1—digestive system—stomach cancer	0.000167	0.00326	CbGeAlD
Dexamethasone—CYP2C8—endocrine gland—stomach cancer	0.000164	0.0032	CbGeAlD
Dexamethasone—NR3C1—bone marrow—stomach cancer	0.000164	0.0032	CbGeAlD
Dexamethasone—CYP19A1—lymph node—stomach cancer	0.000158	0.00309	CbGeAlD
Dexamethasone—PTGS2—lymphoid tissue—stomach cancer	0.000156	0.00304	CbGeAlD
Dexamethasone—PTGS2—digestive system—stomach cancer	0.000154	0.003	CbGeAlD
Dexamethasone—CYP1A1—endocrine gland—stomach cancer	0.000151	0.00296	CbGeAlD
Dexamethasone—ABCC2—lymph node—stomach cancer	0.000151	0.00295	CbGeAlD
Dexamethasone—CYP1B1—lymph node—stomach cancer	0.000148	0.00289	CbGeAlD
Dexamethasone—CYP3A5—endocrine gland—stomach cancer	0.000148	0.00289	CbGeAlD
Dexamethasone—CYP2C8—liver—stomach cancer	0.000148	0.00289	CbGeAlD
Dexamethasone—CYP2B6—endocrine gland—stomach cancer	0.000147	0.00287	CbGeAlD
Dexamethasone—NR3C1—endocrine gland—stomach cancer	0.000147	0.00287	CbGeAlD
Dexamethasone—CYP2C9—endocrine gland—stomach cancer	0.000146	0.00284	CbGeAlD
Dexamethasone—ABCG2—liver—stomach cancer	0.000144	0.00281	CbGeAlD
Dexamethasone—PTGS2—bone marrow—stomach cancer	0.000142	0.00277	CbGeAlD
Dexamethasone—CYP2E1—endocrine gland—stomach cancer	0.000138	0.0027	CbGeAlD
Dexamethasone—ABCB1—hematopoietic system—stomach cancer	0.000137	0.00267	CbGeAlD
Dexamethasone—CYP1A1—liver—stomach cancer	0.000136	0.00266	CbGeAlD
Dexamethasone—CYP3A4—digestive system—stomach cancer	0.000134	0.00262	CbGeAlD
Dexamethasone—CYP3A5—liver—stomach cancer	0.000133	0.00261	CbGeAlD
Dexamethasone—CYP2B6—liver—stomach cancer	0.000133	0.00259	CbGeAlD
Dexamethasone—NR3C1—liver—stomach cancer	0.000132	0.00259	CbGeAlD
Dexamethasone—CYP2D6—digestive system—stomach cancer	0.000132	0.00258	CbGeAlD
Dexamethasone—CYP2C9—liver—stomach cancer	0.000131	0.00256	CbGeAlD
Dexamethasone—PTGS2—endocrine gland—stomach cancer	0.000127	0.00248	CbGeAlD
Dexamethasone—Prednisolone—CYP2A6—stomach cancer	0.000126	0.0928	CrCbGaD
Dexamethasone—ABCB1—epithelium—stomach cancer	0.000125	0.00244	CbGeAlD
Dexamethasone—CYP2E1—liver—stomach cancer	0.000124	0.00243	CbGeAlD
Dexamethasone—PTGS2—liver—stomach cancer	0.000115	0.00224	CbGeAlD
Dexamethasone—ABCB1—pancreas—stomach cancer	0.000111	0.00218	CbGeAlD
Dexamethasone—CYP3A4—endocrine gland—stomach cancer	0.000111	0.00217	CbGeAlD
Dexamethasone—ABCG2—lymph node—stomach cancer	0.00011	0.00215	CbGeAlD
Dexamethasone—CYP2D6—endocrine gland—stomach cancer	0.000109	0.00213	CbGeAlD
Dexamethasone—CYP1A1—lymph node—stomach cancer	0.000105	0.00204	CbGeAlD
Dexamethasone—NR3C1—lymph node—stomach cancer	0.000102	0.00198	CbGeAlD
Dexamethasone—CYP3A4—liver—stomach cancer	0.0001	0.00196	CbGeAlD
Dexamethasone—CYP2D6—liver—stomach cancer	9.85e-05	0.00192	CbGeAlD
Dexamethasone—ABCB1—lymphoid tissue—stomach cancer	9.63e-05	0.00188	CbGeAlD
Dexamethasone—ABCB1—digestive system—stomach cancer	9.51e-05	0.00186	CbGeAlD
Dexamethasone—PTGS2—lymph node—stomach cancer	8.79e-05	0.00172	CbGeAlD
Dexamethasone—ABCB1—bone marrow—stomach cancer	8.77e-05	0.00171	CbGeAlD
Dexamethasone—ABCB1—endocrine gland—stomach cancer	7.86e-05	0.00154	CbGeAlD
Dexamethasone—Feeling abnormal—Fluorouracil—stomach cancer	7.28e-05	0.00075	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—stomach cancer	7.14e-05	0.000735	CcSEcCtD
Dexamethasone—ABCB1—liver—stomach cancer	7.09e-05	0.00138	CbGeAlD
Dexamethasone—Ill-defined disorder—Capecitabine—stomach cancer	7.01e-05	0.000723	CcSEcCtD
Dexamethasone—Urticaria—Fluorouracil—stomach cancer	7.01e-05	0.000723	CcSEcCtD
Dexamethasone—Syncope—Docetaxel—stomach cancer	7e-05	0.000721	CcSEcCtD
Dexamethasone—Conjunctivitis—Methotrexate—stomach cancer	7e-05	0.000721	CcSEcCtD
Dexamethasone—Body temperature increased—Fluorouracil—stomach cancer	6.98e-05	0.000719	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—stomach cancer	6.88e-05	0.000709	CcSEcCtD
Dexamethasone—Loss of consciousness—Docetaxel—stomach cancer	6.86e-05	0.000707	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—stomach cancer	6.84e-05	0.000705	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—stomach cancer	6.82e-05	0.000703	CcSEcCtD
Dexamethasone—Malaise—Capecitabine—stomach cancer	6.82e-05	0.000702	CcSEcCtD
Dexamethasone—Vertigo—Capecitabine—stomach cancer	6.79e-05	0.0007	CcSEcCtD
Dexamethasone—Syncope—Capecitabine—stomach cancer	6.78e-05	0.000699	CcSEcCtD
Dexamethasone—Convulsion—Docetaxel—stomach cancer	6.76e-05	0.000697	CcSEcCtD
Dexamethasone—Hypertension—Docetaxel—stomach cancer	6.74e-05	0.000695	CcSEcCtD
Dexamethasone—Myalgia—Docetaxel—stomach cancer	6.65e-05	0.000685	CcSEcCtD
Dexamethasone—Loss of consciousness—Capecitabine—stomach cancer	6.64e-05	0.000685	CcSEcCtD
Dexamethasone—Asthenia—Irinotecan—stomach cancer	6.61e-05	0.000681	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—stomach cancer	6.61e-05	0.000681	CcSEcCtD
Dexamethasone—Triamcinolone—PTGS2—stomach cancer	6.58e-05	0.0486	CrCbGaD
Dexamethasone—Conjunctivitis—Epirubicin—stomach cancer	6.55e-05	0.000675	CcSEcCtD
Dexamethasone—Hypertension—Capecitabine—stomach cancer	6.53e-05	0.000672	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—stomach cancer	6.5e-05	0.000669	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—stomach cancer	6.46e-05	0.000666	CcSEcCtD
Dexamethasone—Myalgia—Capecitabine—stomach cancer	6.44e-05	0.000663	CcSEcCtD
Dexamethasone—Anxiety—Capecitabine—stomach cancer	6.41e-05	0.000661	CcSEcCtD
Dexamethasone—Oedema—Docetaxel—stomach cancer	6.37e-05	0.000657	CcSEcCtD
Dexamethasone—Anaphylactic shock—Docetaxel—stomach cancer	6.37e-05	0.000657	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—stomach cancer	6.36e-05	0.000656	CcSEcCtD
Dexamethasone—Discomfort—Capecitabine—stomach cancer	6.36e-05	0.000655	CcSEcCtD
Dexamethasone—Infection—Docetaxel—stomach cancer	6.33e-05	0.000652	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—stomach cancer	6.33e-05	0.000652	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—stomach cancer	6.31e-05	0.00065	CcSEcCtD
Dexamethasone—Diarrhoea—Irinotecan—stomach cancer	6.31e-05	0.00065	CcSEcCtD
Dexamethasone—Shock—Docetaxel—stomach cancer	6.27e-05	0.000646	CcSEcCtD
Dexamethasone—Nervous system disorder—Docetaxel—stomach cancer	6.25e-05	0.000644	CcSEcCtD
Dexamethasone—Pruritus—Fluorouracil—stomach cancer	6.25e-05	0.000644	CcSEcCtD
Dexamethasone—Thrombocytopenia—Docetaxel—stomach cancer	6.24e-05	0.000643	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—stomach cancer	6.23e-05	0.000642	CcSEcCtD
Dexamethasone—Tachycardia—Docetaxel—stomach cancer	6.22e-05	0.000641	CcSEcCtD
Dexamethasone—Oedema—Capecitabine—stomach cancer	6.17e-05	0.000636	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—stomach cancer	6.16e-05	0.000635	CcSEcCtD
Dexamethasone—Infection—Capecitabine—stomach cancer	6.13e-05	0.000632	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—stomach cancer	6.11e-05	0.00063	CcSEcCtD
Dexamethasone—Dizziness—Irinotecan—stomach cancer	6.1e-05	0.000628	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—stomach cancer	6.08e-05	0.000627	CcSEcCtD
Dexamethasone—Anorexia—Docetaxel—stomach cancer	6.07e-05	0.000626	CcSEcCtD
Dexamethasone—Shock—Capecitabine—stomach cancer	6.07e-05	0.000625	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—stomach cancer	6.06e-05	0.000625	CcSEcCtD
Dexamethasone—Nervous system disorder—Capecitabine—stomach cancer	6.05e-05	0.000623	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—stomach cancer	6.05e-05	0.000623	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—stomach cancer	6.04e-05	0.000622	CcSEcCtD
Dexamethasone—Diarrhoea—Fluorouracil—stomach cancer	6.04e-05	0.000622	CcSEcCtD
Dexamethasone—Thrombocytopenia—Capecitabine—stomach cancer	6.04e-05	0.000622	CcSEcCtD
Dexamethasone—Tachycardia—Capecitabine—stomach cancer	6.02e-05	0.00062	CcSEcCtD
Dexamethasone—Hyperhidrosis—Capecitabine—stomach cancer	5.96e-05	0.000615	CcSEcCtD
Dexamethasone—Hypotension—Docetaxel—stomach cancer	5.95e-05	0.000614	CcSEcCtD
Dexamethasone—Anorexia—Capecitabine—stomach cancer	5.88e-05	0.000606	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—stomach cancer	5.86e-05	0.000604	CcSEcCtD
Dexamethasone—Vomiting—Irinotecan—stomach cancer	5.86e-05	0.000604	CcSEcCtD
Dexamethasone—Dizziness—Fluorouracil—stomach cancer	5.84e-05	0.000602	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—stomach cancer	5.83e-05	0.000601	CcSEcCtD
Dexamethasone—Rash—Irinotecan—stomach cancer	5.81e-05	0.000599	CcSEcCtD
Dexamethasone—Dermatitis—Irinotecan—stomach cancer	5.81e-05	0.000598	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Docetaxel—stomach cancer	5.81e-05	0.000598	CcSEcCtD
Dexamethasone—Headache—Irinotecan—stomach cancer	5.77e-05	0.000595	CcSEcCtD
Dexamethasone—Hypotension—Capecitabine—stomach cancer	5.76e-05	0.000594	CcSEcCtD
Dexamethasone—Insomnia—Docetaxel—stomach cancer	5.76e-05	0.000594	CcSEcCtD
Dexamethasone—Paraesthesia—Docetaxel—stomach cancer	5.72e-05	0.00059	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—stomach cancer	5.71e-05	0.000589	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—stomach cancer	5.7e-05	0.000587	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—stomach cancer	5.65e-05	0.000583	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—stomach cancer	5.63e-05	0.00058	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—stomach cancer	5.63e-05	0.00058	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.62e-05	0.000579	CcSEcCtD
Dexamethasone—Vomiting—Fluorouracil—stomach cancer	5.61e-05	0.000578	CcSEcCtD
Dexamethasone—Dyspepsia—Docetaxel—stomach cancer	5.61e-05	0.000578	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—stomach cancer	5.6e-05	0.000577	CcSEcCtD
Dexamethasone—Insomnia—Capecitabine—stomach cancer	5.58e-05	0.000575	CcSEcCtD
Dexamethasone—Rash—Fluorouracil—stomach cancer	5.57e-05	0.000574	CcSEcCtD
Dexamethasone—Dermatitis—Fluorouracil—stomach cancer	5.56e-05	0.000573	CcSEcCtD
Dexamethasone—Paraesthesia—Capecitabine—stomach cancer	5.54e-05	0.000571	CcSEcCtD
Dexamethasone—Decreased appetite—Docetaxel—stomach cancer	5.54e-05	0.000571	CcSEcCtD
Dexamethasone—Headache—Fluorouracil—stomach cancer	5.53e-05	0.00057	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Docetaxel—stomach cancer	5.5e-05	0.000567	CcSEcCtD
Dexamethasone—Fatigue—Docetaxel—stomach cancer	5.49e-05	0.000566	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—stomach cancer	5.49e-05	0.000566	CcSEcCtD
Dexamethasone—Nausea—Irinotecan—stomach cancer	5.48e-05	0.000564	CcSEcCtD
Dexamethasone—Pain—Docetaxel—stomach cancer	5.45e-05	0.000561	CcSEcCtD
Dexamethasone—ABCB1—lymph node—stomach cancer	5.43e-05	0.00106	CbGeAlD
Dexamethasone—Dyspepsia—Capecitabine—stomach cancer	5.43e-05	0.00056	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—stomach cancer	5.4e-05	0.000557	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—stomach cancer	5.39e-05	0.000556	CcSEcCtD
Dexamethasone—Betamethasone—PTGS2—stomach cancer	5.39e-05	0.0398	CrCbGaD
Dexamethasone—Decreased appetite—Capecitabine—stomach cancer	5.36e-05	0.000553	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—stomach cancer	5.35e-05	0.000551	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Capecitabine—stomach cancer	5.33e-05	0.000549	CcSEcCtD
Dexamethasone—Fatigue—Capecitabine—stomach cancer	5.32e-05	0.000548	CcSEcCtD
Dexamethasone—Prednisone—ALB—stomach cancer	5.32e-05	0.0393	CrCbGaD
Dexamethasone—Pain—Capecitabine—stomach cancer	5.28e-05	0.000544	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—stomach cancer	5.27e-05	0.000543	CcSEcCtD
Dexamethasone—Feeling abnormal—Docetaxel—stomach cancer	5.25e-05	0.000541	CcSEcCtD
Dexamethasone—Nausea—Fluorouracil—stomach cancer	5.24e-05	0.00054	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—stomach cancer	5.23e-05	0.000539	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—stomach cancer	5.22e-05	0.000538	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Docetaxel—stomach cancer	5.21e-05	0.000537	CcSEcCtD
Dexamethasone—Feeling abnormal—Capecitabine—stomach cancer	5.08e-05	0.000524	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—stomach cancer	5.08e-05	0.000523	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—stomach cancer	5.07e-05	0.000523	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—stomach cancer	5.06e-05	0.000521	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Capecitabine—stomach cancer	5.04e-05	0.00052	CcSEcCtD
Dexamethasone—Abdominal pain—Docetaxel—stomach cancer	5.04e-05	0.000519	CcSEcCtD
Dexamethasone—Body temperature increased—Docetaxel—stomach cancer	5.04e-05	0.000519	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—stomach cancer	5e-05	0.000515	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—stomach cancer	4.95e-05	0.00051	CcSEcCtD
Dexamethasone—Urticaria—Capecitabine—stomach cancer	4.9e-05	0.000505	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—stomach cancer	4.89e-05	0.000503	CcSEcCtD
Dexamethasone—Abdominal pain—Capecitabine—stomach cancer	4.88e-05	0.000503	CcSEcCtD
Dexamethasone—Body temperature increased—Capecitabine—stomach cancer	4.88e-05	0.000503	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—stomach cancer	4.88e-05	0.000502	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—stomach cancer	4.87e-05	0.000502	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—stomach cancer	4.79e-05	0.000494	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—stomach cancer	4.75e-05	0.000489	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—stomach cancer	4.73e-05	0.000488	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—stomach cancer	4.73e-05	0.000488	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—stomach cancer	4.72e-05	0.000487	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—stomach cancer	4.63e-05	0.000477	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—stomach cancer	4.59e-05	0.000473	CcSEcCtD
Dexamethasone—Asthenia—Docetaxel—stomach cancer	4.57e-05	0.000471	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—stomach cancer	4.56e-05	0.00047	CcSEcCtD
Dexamethasone—Infection—Methotrexate—stomach cancer	4.56e-05	0.00047	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—stomach cancer	4.55e-05	0.000468	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—stomach cancer	4.52e-05	0.000466	CcSEcCtD
Dexamethasone—Pruritus—Docetaxel—stomach cancer	4.51e-05	0.000465	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—stomach cancer	4.5e-05	0.000464	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—stomach cancer	4.5e-05	0.000463	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—stomach cancer	4.48e-05	0.000462	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—stomach cancer	4.47e-05	0.00046	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—stomach cancer	4.44e-05	0.000457	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—stomach cancer	4.43e-05	0.000456	CcSEcCtD
Dexamethasone—Asthenia—Capecitabine—stomach cancer	4.43e-05	0.000456	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—stomach cancer	4.39e-05	0.000453	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—stomach cancer	4.38e-05	0.000451	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—stomach cancer	4.38e-05	0.000451	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—stomach cancer	4.37e-05	0.00045	CcSEcCtD
Dexamethasone—Pruritus—Capecitabine—stomach cancer	4.36e-05	0.00045	CcSEcCtD
Dexamethasone—Diarrhoea—Docetaxel—stomach cancer	4.36e-05	0.000449	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—stomach cancer	4.3e-05	0.000443	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—stomach cancer	4.3e-05	0.000443	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—stomach cancer	4.29e-05	0.000442	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—stomach cancer	4.28e-05	0.000441	CcSEcCtD
Dexamethasone—Infection—Epirubicin—stomach cancer	4.27e-05	0.00044	CcSEcCtD
Dexamethasone—Shock—Epirubicin—stomach cancer	4.23e-05	0.000436	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—stomach cancer	4.22e-05	0.000435	CcSEcCtD
Dexamethasone—Diarrhoea—Capecitabine—stomach cancer	4.22e-05	0.000435	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—stomach cancer	4.21e-05	0.000434	CcSEcCtD
Dexamethasone—Dizziness—Docetaxel—stomach cancer	4.21e-05	0.000434	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—stomach cancer	4.21e-05	0.000434	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—stomach cancer	4.21e-05	0.000433	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—stomach cancer	4.19e-05	0.000432	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.18e-05	0.000431	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—stomach cancer	4.15e-05	0.000428	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—stomach cancer	4.15e-05	0.000428	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—stomach cancer	4.15e-05	0.000427	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—stomach cancer	4.13e-05	0.000426	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—stomach cancer	4.12e-05	0.000425	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—stomach cancer	4.1e-05	0.000422	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—stomach cancer	4.1e-05	0.000422	CcSEcCtD
Dexamethasone—Dizziness—Capecitabine—stomach cancer	4.08e-05	0.00042	CcSEcCtD
Dexamethasone—Vomiting—Docetaxel—stomach cancer	4.05e-05	0.000417	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—stomach cancer	4.04e-05	0.000417	CcSEcCtD
Dexamethasone—Rash—Docetaxel—stomach cancer	4.02e-05	0.000414	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—stomach cancer	4.02e-05	0.000414	CcSEcCtD
Dexamethasone—Dermatitis—Docetaxel—stomach cancer	4.01e-05	0.000414	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—stomach cancer	3.99e-05	0.000411	CcSEcCtD
Dexamethasone—Headache—Docetaxel—stomach cancer	3.99e-05	0.000411	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—stomach cancer	3.98e-05	0.00041	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—stomach cancer	3.98e-05	0.00041	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—stomach cancer	3.97e-05	0.000409	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—stomach cancer	3.96e-05	0.000408	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—stomach cancer	3.95e-05	0.000407	CcSEcCtD
Dexamethasone—Pain—Methotrexate—stomach cancer	3.93e-05	0.000405	CcSEcCtD
Dexamethasone—Vomiting—Capecitabine—stomach cancer	3.92e-05	0.000404	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.92e-05	0.000403	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—stomach cancer	3.91e-05	0.000403	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—stomach cancer	3.9e-05	0.000402	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—stomach cancer	3.89e-05	0.000401	CcSEcCtD
Dexamethasone—Rash—Capecitabine—stomach cancer	3.89e-05	0.000401	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—stomach cancer	3.89e-05	0.000401	CcSEcCtD
Dexamethasone—Dermatitis—Capecitabine—stomach cancer	3.89e-05	0.0004	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—stomach cancer	3.88e-05	0.0004	CcSEcCtD
Dexamethasone—Headache—Capecitabine—stomach cancer	3.86e-05	0.000398	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—stomach cancer	3.86e-05	0.000398	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—stomach cancer	3.84e-05	0.000396	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—stomach cancer	3.79e-05	0.000391	CcSEcCtD
Dexamethasone—Nausea—Docetaxel—stomach cancer	3.78e-05	0.00039	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—stomach cancer	3.78e-05	0.00039	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—stomach cancer	3.78e-05	0.00039	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—stomach cancer	3.76e-05	0.000387	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—stomach cancer	3.74e-05	0.000385	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—stomach cancer	3.72e-05	0.000383	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—stomach cancer	3.71e-05	0.000382	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—stomach cancer	3.71e-05	0.000382	CcSEcCtD
Dexamethasone—Pain—Epirubicin—stomach cancer	3.68e-05	0.000379	CcSEcCtD
Dexamethasone—Nausea—Capecitabine—stomach cancer	3.66e-05	0.000378	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—stomach cancer	3.65e-05	0.000376	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—stomach cancer	3.63e-05	0.000374	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—stomach cancer	3.63e-05	0.000374	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.62e-05	0.000373	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—stomach cancer	3.6e-05	0.000371	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—stomach cancer	3.57e-05	0.000368	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—stomach cancer	3.54e-05	0.000365	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—stomach cancer	3.51e-05	0.000362	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—stomach cancer	3.5e-05	0.000361	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—stomach cancer	3.46e-05	0.000356	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.43e-05	0.000354	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—stomach cancer	3.43e-05	0.000353	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—stomach cancer	3.41e-05	0.000352	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—stomach cancer	3.4e-05	0.00035	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—stomach cancer	3.4e-05	0.00035	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—stomach cancer	3.4e-05	0.00035	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—stomach cancer	3.3e-05	0.00034	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—stomach cancer	3.28e-05	0.000338	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—stomach cancer	3.25e-05	0.000335	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—stomach cancer	3.25e-05	0.000335	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—stomach cancer	3.16e-05	0.000326	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—stomach cancer	3.14e-05	0.000324	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—stomach cancer	3.14e-05	0.000324	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—stomach cancer	3.14e-05	0.000324	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—stomach cancer	3.08e-05	0.000318	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—stomach cancer	3.04e-05	0.000313	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—stomach cancer	3.04e-05	0.000313	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—stomach cancer	2.94e-05	0.000303	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—stomach cancer	2.92e-05	0.000301	CcSEcCtD
Dexamethasone—Rash—Methotrexate—stomach cancer	2.9e-05	0.000298	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—stomach cancer	2.89e-05	0.000298	CcSEcCtD
Dexamethasone—Headache—Methotrexate—stomach cancer	2.88e-05	0.000296	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—stomach cancer	2.85e-05	0.000294	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—stomach cancer	2.84e-05	0.000293	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—stomach cancer	2.81e-05	0.00029	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—stomach cancer	2.73e-05	0.000282	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—stomach cancer	2.73e-05	0.000281	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—stomach cancer	2.72e-05	0.00028	CcSEcCtD
Dexamethasone—Rash—Epirubicin—stomach cancer	2.71e-05	0.000279	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—stomach cancer	2.71e-05	0.000279	CcSEcCtD
Dexamethasone—Headache—Epirubicin—stomach cancer	2.69e-05	0.000277	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—stomach cancer	2.63e-05	0.000271	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—stomach cancer	2.55e-05	0.000263	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—stomach cancer	2.53e-05	0.000261	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—stomach cancer	2.51e-05	0.000258	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—stomach cancer	2.51e-05	0.000258	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—stomach cancer	2.49e-05	0.000257	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—stomach cancer	2.36e-05	0.000243	CcSEcCtD
Dexamethasone—CYP1B1—Metabolism—PPARG—stomach cancer	2.49e-06	2.82e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—HMOX1—stomach cancer	2.48e-06	2.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.48e-06	2.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP2A6—stomach cancer	2.47e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSTP1—stomach cancer	2.47e-06	2.79e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSTP1—stomach cancer	2.46e-06	2.79e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—NOS3—stomach cancer	2.46e-06	2.78e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CDKN1B—stomach cancer	2.45e-06	2.78e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TYMS—stomach cancer	2.44e-06	2.76e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—HMOX1—stomach cancer	2.43e-06	2.76e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.43e-06	2.75e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—HMOX1—stomach cancer	2.43e-06	2.75e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IRS2—stomach cancer	2.42e-06	2.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GSTM1—stomach cancer	2.41e-06	2.73e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKR1C3—stomach cancer	2.41e-06	2.73e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPP2R1A—stomach cancer	2.37e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO1—stomach cancer	2.37e-06	2.68e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMP—stomach cancer	2.35e-06	2.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FADS1—stomach cancer	2.35e-06	2.67e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.35e-06	2.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO1—stomach cancer	2.35e-06	2.66e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CAV1—stomach cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—stomach cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TYMS—stomach cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APOA1—stomach cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CAV1—stomach cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—JUN—stomach cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—APOA1—stomach cancer	2.33e-06	2.64e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTP1—stomach cancer	2.33e-06	2.63e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ALB—stomach cancer	2.32e-06	2.63e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GSTM1—stomach cancer	2.31e-06	2.62e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.31e-06	2.61e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—HMOX1—stomach cancer	2.29e-06	2.6e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TYMS—stomach cancer	2.29e-06	2.6e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TYMS—stomach cancer	2.29e-06	2.59e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CD44—stomach cancer	2.28e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MMP9—stomach cancer	2.27e-06	2.57e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSTM1—stomach cancer	2.27e-06	2.57e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CDKN1A—stomach cancer	2.27e-06	2.57e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ERCC2—stomach cancer	2.26e-06	2.56e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PPARG—stomach cancer	2.26e-06	2.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSTM1—stomach cancer	2.26e-06	2.56e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—stomach cancer	2.25e-06	2.55e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PPARG—stomach cancer	2.24e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ALB—stomach cancer	2.24e-06	2.53e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CD44—stomach cancer	2.23e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6ST—stomach cancer	2.22e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—NOS3—stomach cancer	2.22e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.21e-06	2.51e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK8—stomach cancer	2.21e-06	2.5e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SREBF2—stomach cancer	2.2e-06	2.5e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—RORA—stomach cancer	2.18e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ERCC2—stomach cancer	2.18e-06	2.46e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPP2R1A—stomach cancer	2.17e-06	2.46e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TYMS—stomach cancer	2.16e-06	2.45e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—NOS3—stomach cancer	2.14e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTM1—stomach cancer	2.14e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APC—stomach cancer	2.14e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTP1—stomach cancer	2.13e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ERCC2—stomach cancer	2.13e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MTHFR—stomach cancer	2.13e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ERCC2—stomach cancer	2.13e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—HMOX1—stomach cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CD44—stomach cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CD44—stomach cancer	2.08e-06	2.36e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—stomach cancer	2.06e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—stomach cancer	2.06e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MTHFR—stomach cancer	2.05e-06	2.32e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALDOB—stomach cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—stomach cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ALB—stomach cancer	2.03e-06	2.3e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—stomach cancer	2.03e-06	2.3e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—stomach cancer	2.02e-06	2.29e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.02e-06	2.29e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ALB—stomach cancer	2.02e-06	2.28e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ERCC2—stomach cancer	2.01e-06	2.28e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MTHFR—stomach cancer	2e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTHFR—stomach cancer	2e-06	2.26e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6R—stomach cancer	1.98e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TYMS—stomach cancer	1.98e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CAV1—stomach cancer	1.96e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTM1—stomach cancer	1.96e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APOA1—stomach cancer	1.96e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—stomach cancer	1.96e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—NOS3—stomach cancer	1.95e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.94e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK3—stomach cancer	1.93e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—NOS3—stomach cancer	1.93e-06	2.18e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTP1—stomach cancer	1.9e-06	2.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALOX5—stomach cancer	1.9e-06	2.15e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.89e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTHFR—stomach cancer	1.89e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—stomach cancer	1.89e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CAV1—stomach cancer	1.89e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APOA1—stomach cancer	1.88e-06	2.13e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—stomach cancer	1.88e-06	2.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—HMOX1—stomach cancer	1.88e-06	2.13e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.88e-06	2.12e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—stomach cancer	1.87e-06	2.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—DPYD—stomach cancer	1.87e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—stomach cancer	1.86e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SERPINE1—stomach cancer	1.86e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—stomach cancer	1.85e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CAV1—stomach cancer	1.85e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CAV1—stomach cancer	1.84e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOA1—stomach cancer	1.84e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ERCC2—stomach cancer	1.84e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOA1—stomach cancer	1.84e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK1—stomach cancer	1.84e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—stomach cancer	1.84e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—HMOX1—stomach cancer	1.83e-06	2.07e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RHOA—stomach cancer	1.79e-06	2.03e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.78e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—stomach cancer	1.78e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOS3—stomach cancer	1.77e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TYMS—stomach cancer	1.77e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.77e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—NOS3—stomach cancer	1.77e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—stomach cancer	1.76e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—stomach cancer	1.75e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—stomach cancer	1.75e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAV1—stomach cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOA1—stomach cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—stomach cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—stomach cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—stomach cancer	1.73e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TYMS—stomach cancer	1.73e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HMOX1—stomach cancer	1.73e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—stomach cancer	1.73e-06	1.95e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—stomach cancer	1.72e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HMOX1—stomach cancer	1.71e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—stomach cancer	1.71e-06	1.93e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—stomach cancer	1.67e-06	1.89e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.66e-06	1.89e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—stomach cancer	1.66e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—stomach cancer	1.66e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—stomach cancer	1.66e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—stomach cancer	1.65e-06	1.87e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ERCC2—stomach cancer	1.64e-06	1.86e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.63e-06	1.85e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TYMS—stomach cancer	1.63e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—stomach cancer	1.62e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—stomach cancer	1.62e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—stomach cancer	1.62e-06	1.83e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TYMS—stomach cancer	1.61e-06	1.83e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—stomach cancer	1.61e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ERCC2—stomach cancer	1.61e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAV1—stomach cancer	1.6e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—stomach cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—stomach cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOA1—stomach cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.59e-06	1.8e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—stomach cancer	1.55e-06	1.76e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO1—stomach cancer	1.55e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—stomach cancer	1.55e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—stomach cancer	1.54e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—stomach cancer	1.54e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—stomach cancer	1.53e-06	1.73e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.53e-06	1.73e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ERCC2—stomach cancer	1.51e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—stomach cancer	1.51e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ERCC2—stomach cancer	1.5e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—stomach cancer	1.49e-06	1.69e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NOS3—stomach cancer	1.48e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—stomach cancer	1.48e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—stomach cancer	1.46e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—stomach cancer	1.46e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NOS3—stomach cancer	1.43e-06	1.62e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAV1—stomach cancer	1.43e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOA1—stomach cancer	1.42e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—stomach cancer	1.42e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—stomach cancer	1.42e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—stomach cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—stomach cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—stomach cancer	1.4e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NOS3—stomach cancer	1.4e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NOS3—stomach cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAV1—stomach cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOA1—stomach cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—stomach cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—stomach cancer	1.38e-06	1.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CD44—stomach cancer	1.37e-06	1.55e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.36e-06	1.54e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NOS3—stomach cancer	1.32e-06	1.49e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAV1—stomach cancer	1.31e-06	1.49e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOA1—stomach cancer	1.31e-06	1.48e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—stomach cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAV1—stomach cancer	1.3e-06	1.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOA1—stomach cancer	1.3e-06	1.47e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—stomach cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—stomach cancer	1.28e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—stomach cancer	1.26e-06	1.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—stomach cancer	1.26e-06	1.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—stomach cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—stomach cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.24e-06	1.41e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—stomach cancer	1.22e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—stomach cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NOS3—stomach cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—stomach cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—stomach cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—stomach cancer	1.17e-06	1.33e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.17e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—stomach cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK1—stomach cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—stomach cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—stomach cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—stomach cancer	1.14e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HMOX1—stomach cancer	1.13e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—stomach cancer	1.13e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—stomach cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—stomach cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—stomach cancer	1.1e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—stomach cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—stomach cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NOS3—stomach cancer	1.08e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMS—stomach cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NOS3—stomach cancer	1.05e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—stomach cancer	1.05e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—stomach cancer	1.04e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—stomach cancer	1.03e-06	1.16e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—stomach cancer	9.97e-07	1.13e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—stomach cancer	9.95e-07	1.13e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NOS3—stomach cancer	9.92e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ERCC2—stomach cancer	9.89e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—stomach cancer	9.86e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NOS3—stomach cancer	9.83e-07	1.11e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—stomach cancer	9.62e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—stomach cancer	9.3e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—stomach cancer	9.23e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—stomach cancer	9.07e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—stomach cancer	8.99e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—stomach cancer	8.83e-07	1e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAV1—stomach cancer	8.57e-07	9.71e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOA1—stomach cancer	8.55e-07	9.69e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—stomach cancer	8.35e-07	9.46e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—stomach cancer	8.03e-07	9.09e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—stomach cancer	7.86e-07	8.91e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—stomach cancer	7.85e-07	8.89e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—stomach cancer	7.54e-07	8.54e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—stomach cancer	7.41e-07	8.4e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—stomach cancer	6.8e-07	7.7e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—stomach cancer	6.78e-07	7.68e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NOS3—stomach cancer	6.48e-07	7.34e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—stomach cancer	6.07e-07	6.87e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—stomach cancer	5.93e-07	6.72e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—stomach cancer	5.92e-07	6.71e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—stomach cancer	5.58e-07	6.32e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—stomach cancer	5.53e-07	6.26e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.65e-07	4.13e-06	CbGpPWpGaD
